iShares Biotechnology ETF $IBB Shares Sold by Harbour Investment Management LLC

Harbour Investment Management LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 11.0% during the 1st quarter, Holdings Channel reports. The fund owned 25,620 shares of the financial services provider’s stock after selling 3,167 shares during the period. iShares Biotechnology ETF comprises about 2.3% of Harbour Investment Management LLC’s portfolio, making the stock its 10th biggest position. Harbour Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $4,326,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Basepoint Wealth LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter valued at about $26,000. Cary Street Partners Financial LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth about $29,000. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth about $25,000. Caitlin John LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth about $34,000. Finally, Cornerstone Planning Group LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth about $35,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $190.19 on Wednesday. The firm has a 50 day simple moving average of $172.03 and a 200-day simple moving average of $171.35. iShares Biotechnology ETF has a 1-year low of $125.70 and a 1-year high of $191.15.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were paid a $0.0238 dividend. This represents a $0.10 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.